Literature DB >> 1377134

Increased expression of cytokeratin and ferritin-H genes in tumorigenic clones of the SW 613-S human colon carcinoma cell line.

N Modjtahedi1, T Frebourg, N Fossar, C Lavialle, C Cremisi, O Brison.   

Abstract

Subclones of the SW 613-S human colon carcinoma cell line differ by their ability to induce tumors in nude mice and by their level of amplification of the c-myc gene. Clones with a high level of amplification are tumorigenic in nude mice whereas those with a low level are not. Genes overexpressed in the tumorigenic clones as compared to the nontumorigenic ones were searched by differential screening of a cDNA library. Two cDNA clones corresponding to cytokeratin K18 and ferritin-H chain were isolated. The steady state level of the corresponding mRNAs is higher in cells of all tumorigenic clones. The level of cytokeratin K8 mRNA, the specific partner of cytokeratin K18 in intermediate filaments of epithelial cells, is also elevated in these cells. For all three genes, this is mainly due to an increase in the transcription rate, as shown by a nuclear run-on assay. Immunoblotting experiments showed that cytokeratins K8, K18, and K19 are more abundant in cells of tumorigenic clones. The mRNA of the other subunit of apo-ferritin (ferritin-L chain) is expressed at the same level in both types of clones. The mRNAs of cytokeratins K18 and K8 and of ferritin-H chain are also overexpressed in cells of nontumorigenic clones which have acquired a tumorigenic phenotype after transfection of c-myc gene copies.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1377134     DOI: 10.1016/0014-4827(92)90349-d

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  6 in total

1.  Identification of proteins with the CDw75 epitope in human colorectal cancer.

Authors:  Óscar Mariño-Crespo; Almudena Fernández-Briera; Emilio Gil-Martín
Journal:  Oncol Lett       Date:  2017-11-02       Impact factor: 2.967

2.  An Sp1 binding site and the minimal promoter contribute to overexpression of the cytokeratin 18 gene in tumorigenic clones relative to that in nontumorigenic clones of a human carcinoma cell line.

Authors:  M Gunther; T Frebourg; M Laithier; N Fossar; M Bouziane-Ouartini; C Lavialle; O Brison
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

3.  Role of the tumor suppressor PTEN in antioxidant responsive element-mediated transcription and associated histone modifications.

Authors:  Kensuke Sakamoto; Kenta Iwasaki; Hiroyuki Sugiyama; Yoshiaki Tsuji
Journal:  Mol Biol Cell       Date:  2009-01-21       Impact factor: 4.138

4.  Binding of TS1, an anti-keratin 8 antibody, in small-cell lung cancer after 177Lu-DOTA-Tyr3-octreotate treatment: a histological study in xenografted mice.

Authors:  Ann Erlandsson; Eva Forssell-Aronsson; Tomas Seidal; Peter Bernhardt
Journal:  EJNMMI Res       Date:  2011-08-26       Impact factor: 3.138

5.  Use of adenoviral E1A protein to analyze K18 promoter deregulation in colon carcinoma cells discloses a role for CtBP1 and BRCA1.

Authors:  Cécile Delouis; Philippe Prochasson; Madeleine Laithier; Olivier Brison
Journal:  BMC Mol Biol       Date:  2005-04-14       Impact factor: 2.946

6.  Detection of large molecular weight cytokeratin 8 as carrier protein of CA19-9 in non-small-cell lung cancer cell lines.

Authors:  J Fujita; N Dobashi; Y Ohtsuki; Y Ueda; S Bandoh; I Yamadori; J Takahara
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.